Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India-Reference-Cited by-同舟云学术

Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India

Published:2022-09 Issue:9 Volume:22 Page:e240-e253
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Muthu Valliappan,Agarwal Ritesh,Patel Atul,Kathirvel Soundappan,Abraham Ooriapadickal Cherian,Aggarwal Ashutosh Nath,Bal Amanjit,Bhalla Ashu Seith,Chhajed Prashant N,Chaudhry Dhruva,Garg Mandeep,Guleria Randeep,Krishnan Ram Gopal,Kumar Arvind,Maheshwari Uma,Mehta Ravindra,Mohan Anant,Nath Alok,Patel Dharmesh,Rudramurthy Shivaprakash Mandya,Saxena Puneet,Sethuraman Nandini,Singhal Tanu,Soman Rajeev,Thangakunam Balamugesh,Varghese George M,Chakrabarti Arunaloke

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference113 articles.

1. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world;Muthu;Mycopathologia,2021

2. Global epidemiology of mucormycosis;Prakash;J Fungi (Basel),2019

3. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India;Patel;Clin Microbiol Infect,2020

4. Global prevalence of COVID-19-associated mucormycosis (CAM): living systematic review and meta-analysis;Hussain;J Fungi (Basel),2021

5. COVID-19-associated mucormycosis (CAM): an updated evidence mapping;Hussain;Int J Environ Res Public Health,2021

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Lung Changes in Long COVID: Ultra-Low‐Dose vs. Standard‐Dose CT Chest;British Journal of Biomedical Science;2024-09-10

2. Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review;Annals of Medicine;2024-09-02

3. Mucor germinans, a novel dimorphic species resembling Paracoccidioides in a clinical sample: questions on ecological strategy;mBio;2024-08-14

4. Novel targets and improved immunotherapeutic techniques with an emphasis on antimycosal drug resistance for the treatment and management of mycosis;Heliyon;2024-08

5. Pulmonary mucormycosis as a presentation of COVID 19: Case series;Indian Journal of Tuberculosis;2024-07